Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...
Medscape

Are There Contraindications to Switching From Intramuscular to Subcutaneous Depo-Provera?

Adjunct Assistant Professor, School of Health Sciences, George Washington University, Washington, DC; Curriculum Coordinator, Nurse Practitioner Alternatives, Inc ...
The Cardiology Advisor

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot

The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called meningioma.
New York Post

Pfizer faces lawsuit from women who allegedly developed brain tumors after contraceptive injection

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1,000 women who say they developed brain tumors after taking the popular contraceptive injection Depo-Provera. On Monday, ...
Hosted on MSN

Depo-Provera: How Safe Is the Injectable Birth Control?

Depo Provera Brain Tumor: Medroxyprogesterone acetate, a contraceptive injection containing the hormone progestin, is widely known by its brand name, Depo-Provera. Administered every three months, it ...